US Stock MarketDetailed Quotes
ABUS Arbutus Biopharma
- 4.550
- +0.040+0.89%
Close Sep 6 16:00 ET
- 4.548
- -0.002-0.04%
Post 19:15 ET
858.96MMarket Cap-10111P/E (TTM)
4.560High4.390Low1.58MVolume4.530Open4.510Pre Close7.10MTurnover1.17%Turnover RatioLossP/E (Static)188.78MShares4.56052wk High7.01P/B616.57MFloat Cap1.69052wk Low--Dividend TTM135.51MShs Float31.480Historical High--Div YieldTTM3.77%Amplitude0.821Historical Low4.494Avg Price1Lot Size
Arbutus Biopharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -62.89%1.73M | -77.09%1.53M | -53.51%18.14M | -65.65%2.15M | -21.74%4.66M | -67.34%4.65M | -46.85%6.69M | 255.11%39.02M | 94.79%6.25M | 78.20%5.95M |
| Operating revenue | -62.89%1.73M | -77.09%1.53M | -53.51%18.14M | -65.65%2.15M | -21.74%4.66M | -67.34%4.65M | -46.85%6.69M | 255.11%39.02M | 94.79%6.25M | 78.20%5.95M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -2.42%23.1M | -13.06%20.72M | -5.93%96.18M | -16.67%22.67M | 10.46%26.01M | -15.88%23.67M | 2.03%23.83M | 23.72%102.24M | 14.23%27.2M | 12.71%23.55M |
| Selling and administrative expenses | 26.20%7.55M | -4.32%5.31M | 26.02%22.48M | 20.05%5.1M | 67.25%5.84M | 15.00%5.98M | 13.49%5.55M | 4.07%17.83M | -7.57%4.25M | -16.50%3.49M |
| -General and administrative expense | 26.20%7.55M | -4.32%5.31M | 26.02%22.48M | 20.05%5.1M | 67.25%5.84M | 15.00%5.98M | 13.49%5.55M | 4.07%17.83M | -7.57%4.25M | -16.50%3.49M |
| Research and development costs | -12.10%15.55M | -15.72%15.4M | -12.69%73.7M | -23.47%17.56M | 0.57%20.17M | -22.88%17.69M | -1.01%18.28M | 28.86%84.41M | 19.45%22.95M | 20.03%20.06M |
| Operating profit | -12.36%-21.37M | -11.92%-19.18M | -23.43%-78.03M | 2.07%-20.52M | -21.35%-21.35M | -36.83%-19.02M | -59.10%-17.14M | 11.76%-63.22M | -1.70%-20.95M | -0.25%-17.6M |
| Net non-operating interest income expense | 39.15%1.8M | 40.28%1.5M | 1,022.10%5.23M | 124.13%1.42M | 446.42%1.45M | 1,600.00%1.29M | 408.36%1.07M | 117.07%466K | 219.62%634K | 136.05%265K |
| Non-operating interest income | 25.19%1.83M | 21.85%1.55M | 159.49%5.69M | 55.36%1.47M | 115.27%1.49M | 268.94%1.46M | 697.48%1.27M | 1,625.98%2.19M | 3,043.33%943K | 2,470.37%694K |
| Non-operating interest expense | -80.12%34K | -77.78%44K | -73.41%459K | -85.76%44K | -89.28%46K | -64.52%171K | -60.87%198K | -39.59%1.73M | -44.82%309K | -43.70%429K |
| Other net income (expense) | -134.38%-219K | 28.25%-193K | 98.05%-44K | 86.79%-213K | 15.68%-199K | 410.73%637K | -33.83%-269K | -20.78%-2.26M | -757.98%-1.61M | 72.90%-236K |
| Gain on sale of security | -900.00%-8K | -425.00%-13K | 213.64%25K | 450.00%14K | 128.57%6K | -66.67%1K | --4K | -540.00%-22K | ---4K | -40.00%-21K |
| Special income (charges) | -133.18%-211K | 34.07%-180K | 96.91%-69K | 85.89%-227K | 4.65%-205K | 405.77%636K | -35.82%-273K | -19.28%-2.23M | -733.68%-1.61M | 74.88%-215K |
| -Less：Restructuring and merger&acquisition | 133.18%211K | -34.07%180K | -96.91%69K | -85.89%227K | -4.65%205K | -405.77%-636K | 35.82%273K | 19.28%2.23M | 733.68%1.61M | -74.88%215K |
| Income before tax | -15.81%-19.8M | -9.40%-17.88M | -12.05%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -44.32%-16.34M | 14.74%-65.01M | -2.87%-21.93M | 8.30%-17.57M |
| Income tax | 0 | 0 | 0 | 4.44M | 0 | 0 | ||||
| Net income | -15.81%-19.8M | -9.40%-17.88M | -4.89%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -3.64%-16.34M | 8.91%-69.46M | -2.87%-21.93M | 8.30%-17.57M |
| Net income continuous Operations | -15.81%-19.8M | -9.40%-17.88M | -4.89%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -3.64%-16.34M | 8.91%-69.46M | -2.87%-21.93M | 8.30%-17.57M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -15.81%-19.8M | -9.40%-17.88M | -4.89%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -3.64%-16.34M | 8.91%-69.46M | -2.87%-21.93M | 8.30%-17.57M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -15.81%-19.8M | -9.40%-17.88M | -4.89%-72.85M | 11.95%-19.31M | -14.44%-20.1M | -20.45%-17.09M | -3.64%-16.34M | 21.42%-69.46M | -0.17%-21.93M | 27.54%-17.57M |
| Basic earnings per share | -10.00%-0.11 | 0.00%-0.1 | 4.35%-0.44 | 14.29%-0.12 | 0.00%-0.12 | 0.00%-0.1 | 9.09%-0.1 | 44.58%-0.46 | 6.67%-0.14 | 50.00%-0.12 |
| Diluted earnings per share | -10.00%-0.11 | 0.00%-0.1 | 4.35%-0.44 | 14.29%-0.12 | 0.00%-0.12 | 0.00%-0.1 | 9.09%-0.1 | 44.58%-0.46 | 6.67%-0.14 | 50.00%-0.12 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
